Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alter Venture Partners is an active private venture capital firm rather than a drug-development, biotech, pharma, or healthcare operating company. The firm describes itself as a venture capital fund focused on disruptive enterprise companies, with offices spanning Palo Alto, Lisbon, and Madrid and a fund structure associated with Luxembourg. Public sources indicate that it invests in early-stage and growth technology companies and provides strategic support for international expansion. While Alter Venture Partners has participated in some healthtech-related financings, its core business is investment management, not therapeutic R&D, clinical development, manufacturing, or commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alter Venture Partners.